First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) Hits New 12-Month High – Should You Buy?

Shares of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBTGet Free Report) hit a new 52-week high during trading on Wednesday . The company traded as high as GBX 1,778.60 ($21.97) and last traded at GBX 1,772 ($21.89), with a volume of 430 shares trading hands. The stock had previously closed at GBX 1,756.80 ($21.70).

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock Up 0.1 %

The firm has a market cap of Ā£5.22 billion and a P/E ratio of -1,604.73. The stock’s 50 day simple moving average is GBX 1,667.64 and its 200 day simple moving average is GBX 1,602.74. The company has a debt-to-equity ratio of 0.04, a quick ratio of 9.27 and a current ratio of 9.42.

About First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation

(Get Free Report)

Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.

Featured Articles

Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.